Kalnin Christopher P

CEO Kalnin sells 100,000 shares of BKV at $30.06; retains 1,197,243 shares post-sale

Chief Executive Officer Christopher P Kalnin sold 100,000 shares (100.0K shares) of BKV at $30.06 on 2026-03-25, reducing his holdings by 7.7% to 1,197,243 shares (1.20M shares) while retaining a substantial position. The stock is currently trading at $30.14, near its 52-week high of $31.50, following a 10.1% gain over 90 days and a +1.5% move in the past 30 days. The company is trading at a P/E of 8.54 with strong fundamentals: $199.8M in latest-quarter revenue, $76.8M net income, and 47.8% annual revenue growth, indicating robust operational performance. Kalnin's prior BKV trades show inconsistent timing—four of five prior sales occurred in November 2025 with mixed results (ranging from -6.6% to +15.9% over 30 days, and +7.7% to +15.9% over 90 days), with only 1 of 5 prior trades well-timed at the 90-day mark. The current sale at $30.06 occurs near the stock's 52-week high, though whether this disposition signals any particular conviction requires consideration of whether this trade is discretionary or part of a scheduled plan.

CEO Christopher P Kalnin sold 78,281 shares of BKV at $28.04 on 2025-11-17, reducing stake by 5.9% to 1,248,580 shares.

Christopher P Kalnin, BKV's Chief Executive Officer, sold 78,281 shares at $28.04, near the stock's 52-week high of $28.02, following three consecutive sales within four days (2025-11-10, 2025-11-11, 2025-11-14). This pattern of rapid sequential dispositions reduces his holdings from 1,326,861 to 1,248,580 shares post-transaction. The sale occurs at an elevated valuation tier: BKV trades at a P/E of 56.04 despite reporting full-year net income that was negative, and recent quarterly results show net income of $76,850,000 against revenue of $199,762,000 with annual revenue contracting 18.2% year-over-year. The CEO's cross-ticker track record (1 buy with 100% 90-day win rate at +25.9%, 3 prior sells) offers limited context for interpreting BKV-specific activity, as none of his four prior BKV trades yet have measurable 90-day outcomes. The concentration of sales at or near 52-week highs, combined with deteriorating fundamentals and elevated valuation multiples, warrants monitoring of whether this represents discretionary liquidity management or a broader reassessment of the company's trajectory.

CEO Kalnin sold 21,719 shares at $28.00 (Nov 14), retaining 1,326,861 shares; stock at 52-week high, revenue down 18.2% YoY.

Kalnin Christopher P, as Chief Executive Officer, sold 21,719 shares at $28.00 on November 14, 2025, representing a 1.6% reduction in his 1.35M-share position. The sale occurred at the 52-week high price of $27.95 (current), marking significant upward momentum following a 30.7% gain over the prior 30 days. However, the company faces material headwinds: annual revenue declined 18.2% year-over-year, the company was unprofitable over its most recent full fiscal year, and the P/E ratio stands at 55.90—substantially elevated relative to profitability metrics. At the same-ticker level, his most recent prior BKV transaction was a buy on 2024-09-27 (90-day return: +25.9%), though his two most recent sales on 2025-11-11 and 2025-11-10 are too recent for outcome measurement. The confluence of a high-priced exit amid fundamental revenue contraction and negative full-year earnings warrants investor attention to the drivers behind recent price momentum.

BKV CEO Kalnin sells 200,000 shares for $5.3M at $26.16–$27.13 on Nov 10–11, reducing stake 12.9%

Christopher P Kalnin, BKV's Chief Executive Officer, executed 2 separate sales totaling 200,000 shares for $5,329,000.00 between November 10 and 11, 2025, at prices of $26.16 and $27.13 respectively. This represents a 12.9% reduction in his holdings, bringing his post-transaction position to 1,348,580 shares. The sales occurred near the company's 52-week high of $27.21 and amid a 30-day rally of +27.1%, yet BKV trades at a P/E of 53.16 with annual revenue declining 18.2% and full-year net income negative. The CEO's documented cross-ticker track record shows 100% accuracy on buys with a 90-day win rate of +25.9%, but his prior BKV buy on 2024-09-27 also achieved a 90-day gain of +25.9%—suggesting his one prior same-ticker transaction was well-timed, now paired with a material open-market sale at peak valuations while fundamentals deteriorate.

CEO Christopher P Kalnin bought 2,500 shares of BKV at $18.00 on 2024-09-27; 12 other insiders also bought in past 14 days

CEO Christopher P Kalnin purchased 2,500 shares at $18.00, increasing his holdings to 1,483,054 shares on 2024-09-27. This buy coincides with a broader pattern: 12 other insiders have made purchases within the past 14 days, establishing a notable cluster acquisition period. The transaction occurred 4 trading days before the current price of $18.07, indicating minimal price movement since the purchase. The synchronized buying activity across multiple insiders at a recently listed company warrants attention as an indicator of insider positioning during the early public market phase.